Inactive Instrument

News Surface Oncology, Inc.

Equities

SURF

US86877M2098

Summary

Unlock all the news: Be the first to know and act before the market!

Surface Oncology, Inc.(NasdaqCM:SURF) dropped from S&P TMI Index	13/09/23	CI
Surface Oncology, Inc.(NasdaqCM:SURF) dropped from S&P Global BMI Index	13/09/23	CI
Coherus Completes Surface Oncology Acquisition	11/09/23	AQ
Coherus BioSciences Completes Acquisition of Surface Oncology	08/09/23	MT
Surface Oncology : Coherus Completes Surface Oncology Acquisition - Form 8-K	08/09/23	PU
Surface Oncology, Inc. Announces Director Changes	08/09/23	CI
Surface Oncology, Inc.(NasdaqCM:SURF) dropped from NASDAQ Composite Index	08/09/23	CI
Coherus BioSciences, Inc. completed the acquisition of Surface Oncology, Inc. (NasdaqGM : SURF) from Novartis Institutes for BioMedical Research, Inc., Atlas Venture Fund IX, L.P., managed by Atlas Venture L.P., ARK Investment Management LLC, EcoR1 Capital, LLC and others.	07/09/23	CI
Surface Oncology Says Takeover by Coherus BioSciences Gets Backing From ISS, Glass Lewis	31/08/23	MT
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences	31/08/23	AQ
SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF	07/08/23	BU
Surface Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/08/23	CI
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023	02/08/23	AQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SURF, RETA, INPX	28/07/23	PR
Surface Oncology : Report of Independent Registered Public Accounting Firm - Form 8-K	03/07/23	PU
Coherus To Acquire Surface Oncology	26/06/23	AQ
Surface Oncology, Inc.(NasdaqGM:SURF) dropped from Russell Microcap Index	23/06/23	CI
Surface Oncology, Inc.(NasdaqGM:SURF) dropped from Russell Microcap Value Index	23/06/23	CI
Surface Oncology, Inc.(NasdaqGM:SURF) dropped from Russell 3000E Index	23/06/23	CI
Surface Oncology, Inc.(NasdaqGM:SURF) dropped from Russell 3000E Value Index	23/06/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Surface Oncology, Inc.

Equities

SURF

US86877M2098

Summary

Filters